Daniel Albert

Albert D, Aksentijevich S, Hurst S, Fries J, Wolfe F. Modeling Therapeutic Strategies in Rheumatoid Arthritis: Use of Decision Analysis and Markov Models. J Rheum. 2000;27(3):644-652.
Albert D, Hurst S, Kallan M, Wolfe F, Fries J. The results of DMARD treatment on overall outcome of rheumatoid arthritis in a large cohort: Estimates of relative drug effectiveness. Arthritis Rheum. 1999;42:S71.
Albert D, Hurst S, Kallan M, Wolfe F, Fries J. The results of DMARD treatment on overall outcome of rheumatoid arthritis in a large cohort: sequence effects. Arthritis Rhem. 1999;42:S216.
Beauchamp W, Stieber J, Kallan M, Hurst S, Fitzgerald R, Albert D. Who is a good candidate for THR? Developing a predictive model for the outcome of patients undergoing total hip replacement. Arthritis Rheum. 1999;42:S266.
Wolfe F, Albert DA, Pincus T. A survey of United States rheumatologists concerning effectiveness of disease-modifying antirheumatic drugs and prednisone in the treatment of rheumatoid arthritis. Arthritis Care Res. 1998;11(5):375-81.
Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum. 1982;25(6):601-11.